Skip to main content

Want a detailed portfolio tracker?

Sagimet Biosciences (SGMT) P/E (2023 - 2026)

Sagimet Biosciences (SGMT) P/E from Oct 2, 2023 to Jul 20, 2026. The TTM Sagimet Biosciences (SGMT) P/E is -4.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sagimet Biosciences (SGMT)

YearP/EChange
2026-4.53+20.95%
2025-3.74+7.06%
2024-3.50-77.48%
2023-15.53N/A

Comparison Sagimet Biosciences (SGMT) P/E with competitors

Sagimet Biosciences (SGMT) P/E is -4.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.65%
FGENFibroGen Inc0.24-105.30%
CHRSCoherus Biosciences Inc0.85-118.73%
FBIOFortress Biotech Inc0.95-120.95%
ORMPOramed Pharmaceuticals Inc1.50-133.19%
AGENAgenus Inc3.01-166.45%
INVAInnoviva Inc3.15-169.64%
VXRTVaxart Inc3.55-178.37%
CRMDCorMedix Inc3.63-180.11%
CVACCureVac N.V.4.45-198.16%
GLPGGalapagos NV4.86-207.28%
SRPTSarepta Therapeutics Inc4.88-207.79%
ABEOAbeona Therapeutics Inc5.39-218.95%
ABUSArbutus Biopharma Corp5.60-223.55%
ZVRAZevra Therapeutics Inc5.89-229.98%
SPROSpero Therapeutics Inc6.23-237.52%
CGENCompugen Ltd6.31-239.41%
RIGLRigel Pharmaceuticals6.87-251.73%
SLXNSilexion Therapeutics Corp7.30-261.09%
OMEROmeros Corporation9.26-304.42%
AUPHAurinia Pharmaceuticals Inc9.58-311.63%
PLXProtalix BioTherapeutics Inc10.89-340.46%
ACADAcadia Pharmaceuticals Inc11.73-358.96%
TBPHTheravance Biopharma Inc12.26-370.74%
ADMAAdma Biologics Inc12.42-374.18%
HRMYHarmony Biosciences Holdings Inc13.82-405.14%
SABSSAB Biotherapeutics Inc14.14-412.12%
NAGENiagen Bioscience Inc14.82-427.17%
INCYIncyte Corp15.82-449.35%
REGNRegeneron Pharmaceuticals Inc15.86-450.10%
PBYIPuma Biotechnology Inc17.32-482.32%
CPRXCatalyst Pharmaceuticals Inc17.44-485.05%
EXELExelixis Inc17.54-487.22%
TGTXTG Therapeutics Inc18.97-518.75%
MDXGMimedx Group Inc20.55-553.78%
XOMAXOMA Royalty Corp22.87-605.07%
ARGXArgen X SE24.30-636.49%
CTMXCytomX Therapeutics Inc24.82-648.04%
XOMAOXOMA Royalty Corp25.34-659.61%
HALOHalozyme Therapeutics Inc25.62-665.77%
XOMAPXOMA Royalty Corp25.67-666.79%
VRTXVertex Pharmaceuticals Inc27.99-718.12%
RPRXRoyalty Pharma plc - Class A28.69-733.41%
SLNOSoleno Therapeutics Inc29.02-740.65%
ASNDAscendis Pharma A/S30.09-764.28%
LGNDLigand Pharmaceuticals Inc - Class B37.91-937.09%
APLSApellis Pharmaceuticals Inc39.02-961.58%
BMRNBiomarin Pharmaceutical Inc42.21-1032.03%
KRYSKrystal Biotech Inc45.34-1101.17%
ONCBeiGene Ltd69.54-1635.44%
PHARPharming Group N.V.75.03-1756.55%
TECHBio-Techne Corp101.96-2351.22%
VCELVericel Corp109.92-2527.04%
ALNYAlnylam Pharmaceuticals Inc117.96-2704.64%
GMABGenmab140.29-3197.59%
TLXTelix Pharmaceuticals Ltd162.15-3680.30%
CORTCorcept Therapeutics Inc212.86-4799.84%